Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IPTG (Isopropyl β-D-thiogalactoside) is a non-metabolizable galactose analog that induces expression of the LAC OPERON.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 46.00 | |
1 g | In stock | $ 53.00 | |
5 g | In stock | $ 64.00 | |
10 g | In stock | $ 98.00 | |
25 g | Inquiry | $ 136.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | IPTG (Isopropyl β-D-thiogalactoside) is a non-metabolizable galactose analog that induces expression of the LAC OPERON. |
In vitro | At low concentration, IPTG enters cells through lactose permease, but at high concentrations (typically used for protein induction), IPTG can enter the cells independently of lactose permease. |
Kinase Assay | For RNA interference (RNAi), A549 cells are plated at 1,500 cells per well in 96-well plates, allowed to adhere for 24 hours, and transfected with 25 nM siRNA oligonucleotide using Dharmafect 4. Transfected cells are treated with the indicated concentrations of GNE-617 (0.1, 1 , 10 , 100 , and 1000 nM) for 72 hours and viability is evaluated with CellTiter-Glo. Lysates for detection of NAPRT1 protein are collected 72 hours after transfection of 1 million A549 cells in 10 cm dishes. For NAPRT1 re-expression, RERF-LC-MS cells are transfected with pCMV6-AC.NAPRT1 and empty vector pCMV6-AC using Amaxa Nucleofector technology and selected with Geneticin |
Synonyms | Isopropyl β-D-thiogalactoside |
Molecular Weight | 238.3 |
Formula | C9H18O5S |
CAS No. | 367-93-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (251.78 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IPTG 367-93-1 Others inhibit Isopropyl β-D-thiogalactoside Isopropyl b-D-thiogalactoside Inhibitor Isopropyl beta-D-thiogalactoside inhibitor